实验与检验医学
實驗與檢驗醫學
실험여검험의학
EXPERIMENTAL AND LABORATORY MEDICINE
2014年
2期
142-143,152
,共3页
系统性红斑狼疮%T细胞亚群%B淋巴细胞%NK细胞%流式细胞术
繫統性紅斑狼瘡%T細胞亞群%B淋巴細胞%NK細胞%流式細胞術
계통성홍반랑창%T세포아군%B림파세포%NK세포%류식세포술
Systemic lupus erythematosus%T lymphocyte cell subsets%B cells%NK cells%Flow cytometry
目的:探讨T淋巴细胞亚群、B淋巴细胞和NK细胞在系统性红斑狼疮(SLE)中的作用。方法利用流式细胞仪对29例活动期、24例非活动期SLE患者及50例健康对照者的外周血中的CD3+、CD4+、CD8+、CD3-CD16+CD56+(NK)及CD19+(B)淋巴细胞进行检测。结果活动期组与非活动期组及健康对照组比较:CD4+T淋巴细胞、CD4+/CD8+比值及NK细胞明显降低(P<0.05),B淋巴细胞明显增高(P<0.05),CD3+T和CD8+T淋巴细胞无统计学意义(P>0.05)。非活动期组与健康对照组比较,T淋巴细胞各亚群、NK细胞及B淋巴细胞均无统计学意义(P>0.05)。结论检测外周血淋巴细胞亚群,对判断病情及指导临床治疗具有重要意义。
目的:探討T淋巴細胞亞群、B淋巴細胞和NK細胞在繫統性紅斑狼瘡(SLE)中的作用。方法利用流式細胞儀對29例活動期、24例非活動期SLE患者及50例健康對照者的外週血中的CD3+、CD4+、CD8+、CD3-CD16+CD56+(NK)及CD19+(B)淋巴細胞進行檢測。結果活動期組與非活動期組及健康對照組比較:CD4+T淋巴細胞、CD4+/CD8+比值及NK細胞明顯降低(P<0.05),B淋巴細胞明顯增高(P<0.05),CD3+T和CD8+T淋巴細胞無統計學意義(P>0.05)。非活動期組與健康對照組比較,T淋巴細胞各亞群、NK細胞及B淋巴細胞均無統計學意義(P>0.05)。結論檢測外週血淋巴細胞亞群,對判斷病情及指導臨床治療具有重要意義。
목적:탐토T림파세포아군、B림파세포화NK세포재계통성홍반랑창(SLE)중적작용。방법이용류식세포의대29례활동기、24례비활동기SLE환자급50례건강대조자적외주혈중적CD3+、CD4+、CD8+、CD3-CD16+CD56+(NK)급CD19+(B)림파세포진행검측。결과활동기조여비활동기조급건강대조조비교:CD4+T림파세포、CD4+/CD8+비치급NK세포명현강저(P<0.05),B림파세포명현증고(P<0.05),CD3+T화CD8+T림파세포무통계학의의(P>0.05)。비활동기조여건강대조조비교,T림파세포각아군、NK세포급B림파세포균무통계학의의(P>0.05)。결론검측외주혈림파세포아군,대판단병정급지도림상치료구유중요의의。
Objective To investigate the role of T lymphocyte cell subsets, B cells and NK cells in systemic lupus erythe-matosus (SLE). Methods A total of 29 SLE patients in active phase, 24 SLE patients in quiescent phase and 50 healthy controls were enrolled. The CD3+, CD4+, CD8+, CD3-CD16+CD56+ (NK) and CD19+(B) cells in peripheral blood of SLE patients and healthy controls were detected by flow cytometry. Results Compared with the SLE patients in quiescent phase and healthy controls, there was significant difference in CD4+, CD4+/CD8+, B and NK cells in active phase SLE patients(P<0.05), and no significant difference in CD8+cells in active phase SLE patients (P>0.05).There was no significant difference in CD3+,CD4+,CD8+, CD3-CD16+CD56+(NK) and CD19+(B) cells between quiescent phase SLE patients and healthy controls. Conclusion Lymphocyte cell subsets may play an important role in the pathogenesis, progression and therapy of SLE.